Evidence map›Paper›PMID 31323137›Full record

ArticleBritish journal of clinical pharmacology2019

Cancer chemotherapy drug wastage in a tertiary care hospital in India-A 3-month prospective and 1-year retrospective study.

M G Gopisankar, Julie Wahlang, Vikas Jagtap, Chayna Sarkar, L Purnima Devi, Caleb Harris

Abstract read
In one paragraph

Article in British journal of clinical pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

M G GopisankarDepartment of Pharmacology, NEIGRIHMS, India.ORCID 0000-0003-1203-477X
Julie WahlangDepartment of Pharmacology, NEIGRIHMS, India.
Vikas JagtapDepartment of Radiation Oncology, NEIGRIHMS, India.
Chayna SarkarDepartment of Pharmacology, NEIGRIHMS, India.
L Purnima DeviDepartment of Radiation Oncology, NEIGRIHMS, India.
Caleb HarrisDepartment of Surgical Oncology, NEIGRIHMS, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study prospectively quantified wastage of cancer chemotherapeutic drugs in an oncology unit to find the associated cost in 3 months. Retrospective analysis of drug usage for 12 months was also conducted to determine the expected drug loss in 1 year. The effect of vial sharing was evaluated under the assumption of sharing. A significant drug wastage of 19.72% (95% confidence interval [CI], 14.52-24.93%) in 3 months and 17.14% (95% CI 14.69-19.59%) in 1 year occurred in our oncology unit. Number of vials purchased (r = 0.362, p < 0.01), weight (r = -0.146, P < .01) and body surface area (r = -0.26, P < .01) correlated with the drug wasted. Vial sharing assumption showed a 9% (95% CI, 2.5-15.5%) reduction in cost in 1 year.

Indexed as

AdultAgedAntineoplastic AgentsBody Surface AreaDrug CostsFemaleHumansIndiaMaleMiddle AgedNeoplasmsProspective StudiesRetrospective StudiesTertiary Care CentersWaste ProductsAntineoplastic AgentsWaste ProductsCancerchemotherapyhealth economicshealth services researchoncology

Identifiers

PMID31323137
PMCPMC6783588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.